Human SIRPA Alpha Monoclonal Antibody
Produktgrößen
1 mg
£268,00
YR0021-1MG
5 mg
£746,00
YR0021-5MG
20 mg
£1442,00
YR0021-20MG
Über dieses Produkt
- SKU:
- YR0021
- Zusätzliche Namen:
- BIT|CD172A|MFR|MYD-1|P84|PTPNS1|SHPS1|SIRP|SIRPA
- Anwendung:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Klonalität:
- Monoclonal
- Weitere Details:
- Anzurstobart (CC-95251; BMS-986351) is a high-affinity, fully human monoclonal anti-SIRPA Alpha antibody that blocks the binding of CD47 to SIRPA Alpha. Anzurstobart enhances macrophage phagocytic activity against DLBCL cell lines in co-culture models when combined with the antibody Rituximab (HY-P9913). Anzurstobart has the potential for solid and hematologic malignancies research.
- Formulierung:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- SIRPα
- Isotyp:
- IgG1, kappa
- Molekulargewicht:
- 150 kDa
- Reinheit:
- >95%
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- ABclonal Technology
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:YR0021